Tissue targeted antigenic activation of the immune response to treat cancers

Details for Australian Patent Application No. 2007308721 (hide)

Owner Gunn, H.

Inventors Gunn, Harold David

Agent Davies Collison Cave

Pub. Number AU-A-2007308721

PCT Pub. Number WO2008/049231

Priority 11/553,972 27.10.06 US; 2,571,805 20.12.06 CA

Filing date 25 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/049231 Priority application(s): WO2008/049231

18 August 2011 Assignment before Grant

  Gunn, Harold The application has been assigned to QU Biologics Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007308722-Novel vitamin D2 yeast preparation, a method for producing the same, and the use thereof

2007308718-Contextual window-based interface and method therefor